---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-045885"
form_type: "8-K"
ticker: "ESTA"
cik: "0001688757"
company_name: "ESTABLISHMENT LABS HOLDINGS INC."
filed_at: "2026-06-29T12:05:56+00:00"
generated_at: "2026-06-29T12:10:13.524276+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Establishment Labs appoints Taylor Harris to Board of Directors

## Summary
- Taylor Harris appointed to Board effective June 24, 2026; will serve on Audit and Nominating & Governance Committees.
- 25+ years experience in healthcare, medtech, and life sciences; most recently CEO of Cutera and CFO of MyoKardia (acquired by BMS for $13.1B).
- New director receives initial equity grant of $170,000 under updated non-employee director compensation policy.
- Harris's appointment fills a board seat until the 2027 annual meeting; no arrangements or material interests with other parties.

## SEC filing metadata
- accession: 0001628280-26-045885
- form_type: 8-K
- ticker: ESTA
- cik: 0001688757
- company_name: ESTABLISHMENT LABS HOLDINGS INC.
- filed_at: 2026-06-29T12:05:56+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1688757/000162828026045885/0001628280-26-045885-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1688757/000162828026045885/esta-20260629.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-045885
- JSON: https://secwatch.observer/filing/0001628280-26-045885.json
- Plain text: https://secwatch.observer/filing/0001628280-26-045885.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.